{"cluster": 36, "subcluster": 5, "abstract_summ": " COVID-19 emerges as a pandemic disease with high mortality . Development of effective prevention and treatment is an urgent need . Early reports suggest IL6 receptor-blocking antibody used to manage toxicities associated with chimeric antigen receptor T-cell therapy may help control cytokine storms ."}